https://frontier.patientwing.com/
Frontier Clinical Study - Assessing Inebilizumab and Blinatumomab in Select Autoimmune Diseases
Currently Recruiting. A clinical study for adults with treatment-resistant lupus, lupus nephritis, or rheumatoid arthritis.
clinical studyfrontierassessinginebilizumab
https://adisinsight.springer.com/drugsafety/803801566?error=cookies_not_supported&code=37187eb2-1440-449d-b20a-4ae23a81345f
Inebilizumab/pembrolizumab - AdisInsight
A 66-year-old woman exhibited lack of efficacy during treatment with inebilizumab for aquaporin-4-IgG seropositive (AQP4-IgG+) neuromyelitis optica spectrum
inebilizumabpembrolizumabadisinsight
https://adisinsight.springer.com/drugsafety/803929786?error=cookies_not_supported&code=a1e7e115-8e2f-4a38-a2c5-8cb474d05759
Inebilizumab/Rituximab - AdisInsight
In a multicentre Chinese cohort of 229 patients [age not stated; sex not stated] with aquaporin-4 immunoglobulin G seropositive neuromyelitis optica spectrum
inebilizumabrituximabadisinsight
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=834db232-afb0-4dcf-93e0-009ce8245c20
DailyMed - UPLIZNA- inebilizumab injection
dailymedinebilizumabinjection